Kidswell Bio Corporation (TYO:4584)
Japan · Delayed Price · Currency is JPY 274.00
+9.00 (3.40%)
At close: Mar 6, 2026
Kidswell Bio Market Cap
Kidswell Bio has a market cap or net worth of 13.59 billion as of March 6, 2026. Its market cap has increased by 206.74% in one year.
Market Cap
13.59B
Enterprise Value
12.43B
Revenue
7.06B
Ranking
n/a
PE Ratio
567.06
Stock Price
274.00
Market Cap Chart
Since November 30, 2012, Kidswell Bio's market cap has increased from 2.73B to 13.59B, an increase of 397.29%. That is a compound annual growth rate of 12.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.59B | 34.99% |
| Dec 30, 2025 | 10.07B | 125.16% |
| Dec 30, 2024 | 4.47B | -11.75% |
| Dec 29, 2023 | 5.07B | -40.50% |
| Dec 30, 2022 | 8.52B | -45.05% |
| Dec 30, 2021 | 15.50B | 7.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 17.43B |
| ReproCELL | 16.00B |
| Kubota Pharmaceutical Holdings | 15.12B |
| Stella Pharma | 14.97B |
| CanBas | 14.41B |
| Immuno-Biological Laboratories | 13.40B |
| Nano Holdings | 12.66B |
| CellSeed | 11.46B |